168638 research outputs found
Sort by
2007 Laos - Luang Prabang (Ages 13-15) Global Youth Tobacco Survey (GYTS) Fact Sheet
2007 Laos - Luang Prabang (Ages 13-15) Global Youth Tobacco Survey (GYTS) Fact Shee
Hepatitis B, chronic Probable: (Week 42) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 19 2024
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hepatitis B, chronic Probable cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov
Hantavirus pulmonary syndrome: (Week 42) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 19 2024
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hantavirus pulmonary syndrome cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov
Legionellosis: (Week 42) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 19 2024
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Legionellosis cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov
Measles Indigenous: (Week 42) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 19 2024
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Measles Indigenous cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov
Viral hemorrhagic fevers Marburg virus: (Week 42) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 19 2024
Marburg virus, Viral hemorrhagic fevers cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by jurisdiction. Case notifications for national notifiable conditions are voluntarily submitted to CDC. NNDSS data are provisional and subject to change until reconciled with state and territorial providers. Weekly cumulative counts may increase or decrease as updates occur. Finalized annual data often differ from provisional counts. CDC aggregates data for national notifiable diseases and conditions on a weekly and annual basis. To see specific surveillance Case Definitions for this disease, go to: https://ndc.services.cdc.gov/2024-42-table 1398-H.pd
Enrollment in High-deductible Health Plans Among People Younger Than Age 65 With Private Health Insurance: United States, 2019\u20132023
This report provides a comprehensive look at enrollment in high-deductible health plans (HDHP), including consumer-directed health plans (CDHP) among privately insured people younger than age 65
Dementia Mortality Among Adults Age 65 and Older: United States, 2018-2022
Estimates in this report are based on the National Vital Statistics System mortality files, accessed via CDC WONDER (1). Dementia deaths are identified using the International Classification of Diseases, 10th Revision underlying cause-of-death codes F01, vascular dementia; F03, unspecified dementia; G30, Alzheimer disease; and G31, other degenerative diseases of nervous system, not elsewhere classified (5). Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population (6). Pairwise comparisons of rates were conducted using a z test with an alpha level of 0.05. Changes in the distribution of place of death were assessed using the Cochran\u2013Armitage test for trends, a modified chi-squared test
Biobehavioral Survey (BBS) among Venezuelan migrants living in Lima/Callao and Trujillo: FINAL REPORT 2023
Results from biobehavioral survey (BBS)/population size estimation (PSE) of Venezuelan Migrants in Lima/Callao and Trujillo in Peru, 202
J Epidemiol Community Health
BackgroundWe analysed the impact of breastfeeding, antiretroviral drugs and health service factors on cumulative (6 weeks to 18 months) vertical transmission of HIV (MTCT) and \u2018MTCT-or-death\u2019, in South Africa, and compared estimates with global impact criteria to validate MTCT elimination: (1) 6 weeks to 18 months) was 1.7% (95% CI 1.2% to 2.4%). Cumulative \u2018MTCT-or-death\u2019 was 6.3% (95% CI 5.5% to 7.3%); 81% and 62% of cumulative MTCT and \u2018MTCT-or-death\u2019, respectively, occurred by 6 months. Postnatal MTCT increased with unknown maternal CD4-cell-count (adjusted HR (aHR 2.66 (1.5\u20135.6)), undocumented maternal HIV status (aHR 2.21 (1.0\u20134.7)) and exclusive (aHR 2.3 (1.0\u20135.2)) or mixed (aHR 3.7 (1.2\u201311.4)) breastfeeding. Cumulative \u2018MTCT-or death\u2019 increased in households with \u2018no refrigerator\u2019 (aHR 1.7 (1.1\u20132.9)) and decreased if infants used nevirapine at 6 weeks (aHR 0.4 (0.2\u20130.9)).ConclusionsWhile the <5% final MTCT target was met, the case rate was 25-times above target. Systems are needed in the first 6 months post-delivery to optimise HEU health and fast-track ART initiation in newly diagnosed mothers.U2G GH001150/GH/CGH CDC HHSUnited States/U2G PS001137/PS/NCHHSTP CDC HHSUnited States/PEPFAR/PEPFARUnited States